In this presentation, Dr. Peyper covers the role autoantibodies play in cancer and highlights case studies illustrating the utility of autoantibodies as predictive biomarkers.

Click to Watch

  • Cancer is one of the most complex disorders; no two cases of the same tumor are in fact the same on a molecular level.
  • As cancer cells rapidly evolve on a microscale, trying to develop therapeutics for established malignancy is like closing the stable door after the horse has bolted.
  • Directly functional proteins like antibodies give us a glimpse into what the immune system has seen and the decisions it has made, providing an excellent window into the mechanisms of health and disease in order to enhance efficiency and efficacy of translation from bench to bedside.